Biodisponibilité And NotPhilip Sassene
List of bibliographic references
Number of relevant bibliographic references: 13.Ident. | Authors (with country if any) | Title |
---|---|---|
000802 | Mark Farrell [Australie] ; Thomas K. Kuhn [Australie, Allemagne] ; Lynne M. Macdonald [Australie] ; Todd M. Maddern [Australie] ; Daniel V. Murphy [Australie] ; Phillip A. Hall [Australie] ; BHUPINDER PAL SINGH [Australie] ; Karen Baumann [Australie, France] ; Evelyn S. Krull [Australie] ; Jeff A. Baldock [Australie] | Microbial utilisation of biochar-derived carbon |
001018 | Marcela Calabi-Floody [Chili] ; Gabriela Velasquez [Chili] ; Liliana Gianfreda [Italie] ; Surinder Saggar [Nouvelle-Zélande] ; Nanthi Bolan [Australie] ; Cornelia Rumpel [France] ; Maria Luz Mora [Chili] | Improving bioavailability of phosphorous from cattle dung by using phosphatase immobilized on natural clay and nanoclay |
001037 | C. S. Hassler [Australie] ; V. Schoemann [Pays-Bas] ; M. Boye [France] ; A. Tagliabue [Afrique du Sud] ; M. Rozmarynowycz [États-Unis] ; R. M. L. Mckay [États-Unis] | IRON BIOAVAILABILITY IN THE SOUTHERN OCEAN |
001822 | Houda Sabboh-Jourdan [Australie] ; Fanny Valla [France] ; Indah Epriliati [Australie] ; Michael J. Gidley [Australie] | Organic acid bioavailability from banana and sweet potato using an in vitro digestion and Caco-2 cell model |
002F89 | Estelle Bakkaus [France] ; Richard N. Collins [Australie] ; Jean-Louis Morel [France] ; Barbara Gouget [France] | Potential phytoavailability of anthropogenic cobalt in soils as measured by isotope dilution techniques |
003254 | Jean F. Cuine [Australie] ; Claire L. Mcevoy [Australie] ; William N. Charman [Australie] ; Colin W. Pouton [Australie] ; Glenn A. Edwards [Australie] ; Hassan Benameur [France] ; Christopher J. H. Porter [Australie] | Evaluation of the Impact of Surfactant Digestion on the Bioavailability of Danazol after Oral Administration of Lipidic Self-Emulsifying Formulations to Dogs |
003350 | Marianne Stenr D [Norvège] ; Jeanne Perceval [Norvège, France] ; Pierre Benoit [France] ; Marit Almvik [Norvège] ; Randi I. Bolli [Norvège] ; Ole Martin Ekio [Norvège] ; Tore E. Sveistmp [Norvège] ; Jens Kvaeemer [Norvège] | Cold climatic conditions : Effects on bioavailability and leaching of the mobile pesticide metribuzin in a silt loam soil in Norway |
004532 | Antoine Younes [France] ; Salvatore Pepe [Australie] ; Darice Yoshishige [États-Unis] ; James L. Caffrey [États-Unis] ; Edward G. Lakatta [États-Unis] | Ischemic preconditioning increases the bioavailability of cardiac enkephalins |
005572 | Michael Kassiou [France] ; Christian Loc'H [France] ; Michel Bottlaender [France] ; Karine Mardon [Australie] ; Michele Ottaviani [France] ; Christine Coulon [France] ; Andrew Katsifis [Australie] ; Bernard Maziere [France] | (+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET |
005744 | Shelley F. Stone [Australie] ; Patricia Price [Australie] ; Jean Brochier [France] ; Martyn A. French [Australie] | Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy |
005D04 | Ross E. Mcmurtrie [Australie] ; Roderick C. Dewar [France] ; Belinda E. Medlyn [Royaume-Uni] ; Mark P. Jeffreys [Australie] | Effects of elevated [CO2] on forest growth and carbon storage : a modelling analysis of the consequences of changes in litter quality/quantity and root exudation |
006070 | M.-L. Navas [Australie, France] ; E. Garnier [France, Australie] ; M. P. Austin [Australie] ; R. M. Gifford [Australie] | Effect of competition on the responses of grasses and legumes to elevated atmospheric CO2 along a nitrogen gradient : differences between isolated plants, monocultures and multi-species mixtures |
006658 | L. P. Rivory [Australie] ; M.-C. Haaz [France] ; P. Canal [France] ; F. Lokiec [France] ; J.-P. Armand [France] ; J. Robert [France] | Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials |
This area was generated with Dilib version V0.6.33. |